BioVie Inc. (BIVI)
NASDAQ: BIVI · IEX Real-Time Price · USD
-0.002 (-0.39%)
At close: Apr 19, 2024, 4:00 PM
+0.004 (0.72%)
After-hours: Apr 19, 2024, 7:58 PM EDT

BioVie Statistics

Total Valuation

BioVie has a market cap or net worth of $26.72 million. The enterprise value is $16.76 million.

Market Cap 26.72M
Enterprise Value 16.76M

Important Dates

The next estimated earnings date is Friday, May 10, 2024, after market close.

Earnings Date May 10, 2024
Ex-Dividend Date n/a

Share Statistics

BioVie has 54.92 million shares outstanding. The number of shares has increased by 22.46% in one year.

Shares Outstanding 54.92M
Shares Change (YoY) +22.46%
Shares Change (QoQ) +3.89%
Owned by Insiders (%) 43.25%
Owned by Institutions (%) 4.49%
Float 22.51M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 3.57
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.47, with a Debt / Equity ratio of 1.37.

Current Ratio 1.47
Quick Ratio n/a
Debt / Equity 1.37
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -9.77

Financial Efficiency

Return on equity (ROE) is -332.20% and return on invested capital (ROIC) is -250.16%.

Return on Equity (ROE) -332.20%
Return on Assets (ROA) -137.90%
Return on Capital (ROIC) -250.16%
Revenue Per Employee n/a
Profits Per Employee -$2.40M
Employee Count 18
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -94.06% in the last 52 weeks. The beta is 1.21, so BioVie's price volatility has been higher than the market average.

Beta (1Y) 1.21
52-Week Price Change -94.06%
50-Day Moving Average 0.80
200-Day Moving Average 2.48
Relative Strength Index (RSI) 36.94
Average Volume (30 Days) 2,614,254

Short Selling Information

The latest short interest is 1.48 million, so 2.69% of the outstanding shares have been sold short.

Short Interest 1.48M
Short Previous Month 1.54M
Short % of Shares Out 2.69%
Short % of Float 6.57%
Short Ratio (days to cover) 0.23

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -44.41M
Pretax Income -43.27M
Net Income -43.27M
EBITDA -39.04M
EBIT -39.25M
Earnings Per Share (EPS) -$1.17
Full Income Statement

Balance Sheet

The company has $20.23 million in cash and $10.26 million in debt, giving a net cash position of $9.97 million or $0.18 per share.

Cash & Cash Equivalents 20.23M
Total Debt 10.26M
Net Cash 9.97M
Net Cash Per Share $0.18
Equity / Book Value 7.49M
Book Value Per Share 0.14
Working Capital 6.58M
Full Balance Sheet

Cash Flow

Operating Cash Flow -41.11M
Capital Expenditures n/a
Free Cash Flow -41.11M
FCF Per Share -$1.08
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BioVie does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -22.46%
Shareholder Yield -22.46%
Earnings Yield -161.91%
FCF Yield -153.85%

Analyst Forecast

The average price target for BioVie is $8.00, which is 1,544.40% higher than the current price. The consensus rating is "Buy".

Price Target $8.00
Price Target Difference 1,544.40%
Analyst Consensus Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on November 22, 2019. It was a reverse split with a ratio of 1:125.

Last Split Date Nov 22, 2019
Split Type Reverse
Split Ratio 1:125


Altman Z-Score n/a
Piotroski F-Score 2